Canopy Growth (CGC) vs Trulieve Cannabis Subordinate Voting Shares (TRLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Trulieve Cannabis Subordinate Voting Shares (TRLV) has outperformed Canopy Growth (CGC) over the past year, gaining 18.0% versus a loss of 44.7%. Over five years, TRLV leads with a -60.5% price change compared with -99.4% for CGC. Trulieve Cannabis Subordinate Voting Shares is the larger company by market cap ($2.00 billion vs $380.5 million), about 5.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CGC | TRLV |
|---|---|---|
| Share price | $0.8468 | $10.37 |
| Market cap | $380.47M | $2.00B |
| 1-day change | -3.39% | -3.80% |
| YTD return | -25.72% | +19.33% |
| 1-year return | -44.65% | +17.97% |
| 5-year return | -99.37% | -60.45% |
| Forward P/E | — | 18.63 |
| EPS (TTM) | $-0.45 | $-2.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.18B |
| Revenue growth (YoY) | — | -0.45% |
| Net income (latest FY) | — | $-122.25M |
| Gross margin | — | 60.21% |
| Operating margin | — | 12.15% |
| Net margin | — | -10.35% |
| 52-week high | $2.38 | $13.28 |
| 52-week low | $0.81 | $4.62 |
| Distance from 52-week high | -64.42% | -21.91% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +41.71% | +75.31% |
| Average volume | 2.77M | 1.61M |
| Shares outstanding | 423.04M | 170.16M |
| Employees | 1,128 | 5,000 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Trulieve Cannabis Subordinate Voting Shares is about 5.2 times larger than Canopy Growth by market value ($2.00B vs $380.47M).
- TRLV has outperformed CGC by 62.6 percentage points over the past year.
About Canopy Growth
CGC stock →Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.
Health Care · Medicinal Chemicals and Botanical Products · 1,128 employees
About Trulieve Cannabis Subordinate Voting Shares
TRLV stock →Trulieve Cannabis Corp. operates as a cannabis retailer in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 5,000 employees
CGC vs TRLV FAQ
Which is bigger, Canopy Growth or Trulieve Cannabis Subordinate Voting Shares?
Trulieve Cannabis Subordinate Voting Shares (TRLV) is larger, with a market capitalization of $2.00B compared with $380.47M for Canopy Growth (CGC).
Which stock has performed better over the past year, CGC or TRLV?
TRLV returned +17.97% over the past 12 months, compared with -44.65% for CGC (price return, excluding dividends). Past performance does not predict future results.
Are Canopy Growth and Trulieve Cannabis Subordinate Voting Shares in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.